GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Modern Chinese Medicine Group Co Ltd (HKSE:01643) » Definitions » 5-Year RORE %

Modern Chinese Medicine Group Co (HKSE:01643) 5-Year RORE % : -8.90% (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Modern Chinese Medicine Group Co 5-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Modern Chinese Medicine Group Co's 5-Year RORE % for the quarter that ended in Jun. 2024 was -8.90%.

The industry rank for Modern Chinese Medicine Group Co's 5-Year RORE % or its related term are showing as below:

HKSE:01643's 5-Year RORE % is ranked worse than
63.98% of 880 companies
in the Drug Manufacturers industry
Industry Median: 1.815 vs HKSE:01643: -8.90

Modern Chinese Medicine Group Co 5-Year RORE % Historical Data

The historical data trend for Modern Chinese Medicine Group Co's 5-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Modern Chinese Medicine Group Co 5-Year RORE % Chart

Modern Chinese Medicine Group Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
5-Year RORE %
Get a 7-Day Free Trial - - - - -

Modern Chinese Medicine Group Co Semi-Annual Data
Dec17 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
5-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - -8.90 -

Competitive Comparison of Modern Chinese Medicine Group Co's 5-Year RORE %

For the Drug Manufacturers - General subindustry, Modern Chinese Medicine Group Co's 5-Year RORE %, along with its competitors' market caps and 5-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Modern Chinese Medicine Group Co's 5-Year RORE % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Modern Chinese Medicine Group Co's 5-Year RORE % distribution charts can be found below:

* The bar in red indicates where Modern Chinese Medicine Group Co's 5-Year RORE % falls into.


;
;

Modern Chinese Medicine Group Co 5-Year RORE % Calculation

Modern Chinese Medicine Group Co's 5-Year RORE % for the quarter that ended in Jun. 2024 is calculated as:

5-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 5-year -Cumulative Dividends per Share for 5-year )
=( 0.017-0.12 )/( 0.563-0.017 )
=-0.103/0.546
=-18.86 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 5-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Jun. 2024 and 5-year before.


Modern Chinese Medicine Group Co  (HKSE:01643) 5-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 5-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Modern Chinese Medicine Group Co 5-Year RORE % Related Terms

Thank you for viewing the detailed overview of Modern Chinese Medicine Group Co's 5-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Modern Chinese Medicine Group Co Business Description

Traded in Other Exchanges
N/A
Address
No. 88 Jinwei Road, Hebei, Chengde, CHN, 068150
Modern Chinese Medicine Group Co Ltd is engaged in the production of Proprietary Chinese Medicines. It offers both OTC and prescribed medicines intended for use by the Middle-aged and the Elderly in the PRC. Its products include liver protection tablets, Shanmei capsules, Qi and blood supplement pills, and Xiaohuoluo pills among others. Geographically, the company derives its key revenue from the People's Republic of China.
Executives
Sun Xinlei 2201 Interest of corporation controlled by you
Xian Dai Sheng Wu Ke Ji Ji Tuan Kong Gu You Xian Gong Si 2101 Beneficial owner
Xie Wei 2201 Interest of corporation controlled by you

Modern Chinese Medicine Group Co Headlines

No Headlines